Social Aspects of Drug Discovery, Development and Commercialization
Autor Odilia Osakwe, Syed A.A. Rizvien Limba Engleză Paperback – 10 feb 2016
This book provides thoughtful and valuable discussions and analysis of the social challenges and potential opportunities through all stages of the pharmaceutical process, from inception through marketing. With a unique focus on the social factors that increasingly play a role in how drug development is planned, structured, and executed throughout the drug product lifecycle, this is an essential resource for students, professors, and researchers who seek a better understanding of the interface between the pharmaceutical industry, health care systems, and society.
- Organized in a sequence of interrelated theories and principles that provide the foundation for increased understanding of the relevant social aspects
- Includes analysis of important new advances, key scientific and strategic issues, and overviews of recent progress in drug development
- Provides a global perspective with examples from developed areas, such as the US, Japan, Canada and Europe, as well as faster-growing and emerging economies including Brazil, Russia, India, and China
- Serves as an essential resource for students, professors, and researchers who seek a better understanding of the interface between the pharmaceutical industry, health care systems, and society
Preț: 408.06 lei
Preț vechi: 429.53 lei
-5% Nou
Puncte Express: 612
Preț estimativ în valută:
78.09€ • 81.12$ • 64.87£
78.09€ • 81.12$ • 64.87£
Carte tipărită la comandă
Livrare economică 27 ianuarie-10 februarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780128022207
ISBN-10: 0128022205
Pagini: 324
Dimensiuni: 152 x 229 x 13 mm
Greutate: 0.52 kg
Editura: ELSEVIER SCIENCE
ISBN-10: 0128022205
Pagini: 324
Dimensiuni: 152 x 229 x 13 mm
Greutate: 0.52 kg
Editura: ELSEVIER SCIENCE
Public țintă
Graduate and postgraduate students in pharmaceutical science, pharmacology and toxicology; policy-makers; professionals with interest in the current, past and future performance of the pharmaceutical marketCuprins
SECTION I: PHARMACEUTICAL INDUSTRY, SOCIETY, AND GOVERNANCE1. Pharmaceutical Regulation: The Role of Government2. Trends in Innovation and the Business of Drug Discovery3. Cash Flow Valley of Death: A Pitfall in Drug Discovery
SECTION II: THE DRUG DISCOVERY CYCLE I: DISCOVERY AND PRECLINICAL DRUG DEVELOPMENT4. Prediscovery Research: Challenges and Opportunities5. The Significance of Discovery Screening and Structure Optimization Studies6. Preclinical In Vitro Studies – Development and Applicability7. Animal Utilization in Drug Development – Clinical, Legal, and Ethical Dimensions8. Pharmaceutical Formulation and Manufacturing Development: Strategies and Issues
SECTION III: THE DRUG DISCOVERY CYCLE II: CLINICAL DEVELOPMENT9. Clinical Development: Ethics and Realities 10. Pharmacogenomics in Drug Discovery, Prospects and Clinical Applicability
SECTION IV: THE DRUG DISCOVERY CYCLE III: AUTHORIZATION AND MARKETING11. Patents, Exclusivities, and Evergreening Strategies 12. Drug Pricing and Control for Pharmaceutical DrugsIndex
SECTION II: THE DRUG DISCOVERY CYCLE I: DISCOVERY AND PRECLINICAL DRUG DEVELOPMENT4. Prediscovery Research: Challenges and Opportunities5. The Significance of Discovery Screening and Structure Optimization Studies6. Preclinical In Vitro Studies – Development and Applicability7. Animal Utilization in Drug Development – Clinical, Legal, and Ethical Dimensions8. Pharmaceutical Formulation and Manufacturing Development: Strategies and Issues
SECTION III: THE DRUG DISCOVERY CYCLE II: CLINICAL DEVELOPMENT9. Clinical Development: Ethics and Realities 10. Pharmacogenomics in Drug Discovery, Prospects and Clinical Applicability
SECTION IV: THE DRUG DISCOVERY CYCLE III: AUTHORIZATION AND MARKETING11. Patents, Exclusivities, and Evergreening Strategies 12. Drug Pricing and Control for Pharmaceutical DrugsIndex